These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 9743529)
1. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. Gil-Torregrosa BC; Raúl Castaño A; Del Val M J Exp Med; 1998 Sep; 188(6):1105-16. PubMed ID: 9743529 [TBL] [Abstract][Full Text] [Related]
2. Generation of MHC class I peptide antigens by protein processing in the secretory route by furin. Gil-Torregrosa BC; Castaño AR; López D; Del Val M Traffic; 2000 Aug; 1(8):641-51. PubMed ID: 11208152 [TBL] [Abstract][Full Text] [Related]
3. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation. López D; Gil-Torregrosa BC; Bergmann C; Del Val M J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863 [TBL] [Abstract][Full Text] [Related]
4. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules. Bai A; Forman J J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300 [TBL] [Abstract][Full Text] [Related]
5. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo. Medina F; Ramos M; Iborra S; de León P; Rodríguez-Castro M; Del Val M J Immunol; 2009 Oct; 183(7):4639-47. PubMed ID: 19752221 [TBL] [Abstract][Full Text] [Related]
6. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation. Smith DC; Gallimore A; Jones E; Roberts B; Lord JM; Deeks E; Cerundolo V; Roberts LM J Immunol; 2002 Jul; 169(1):99-107. PubMed ID: 12077234 [TBL] [Abstract][Full Text] [Related]
7. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases. Saveanu L; Fruci D; van Endert P Mol Immunol; 2002 Oct; 39(3-4):203-15. PubMed ID: 12200051 [TBL] [Abstract][Full Text] [Related]
8. TAP-independent presentation of CTL epitopes by Trojan antigens. Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. del Val M; Hengel H; Häcker H; Hartlaub U; Ruppert T; Lucin P; Koszinowski UH J Exp Med; 1992 Sep; 176(3):729-38. PubMed ID: 1324970 [TBL] [Abstract][Full Text] [Related]
10. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules. Campbell DJ; Serwold T; Shastri N J Immunol; 2000 Jan; 164(1):168-75. PubMed ID: 10605008 [TBL] [Abstract][Full Text] [Related]
11. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
12. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Grommé M; Neefjes J Mol Immunol; 2002 Oct; 39(3-4):181-202. PubMed ID: 12200050 [TBL] [Abstract][Full Text] [Related]
13. Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes. Del-Val M; López D Mol Immunol; 2002 Oct; 39(3-4):235-47. PubMed ID: 12200053 [TBL] [Abstract][Full Text] [Related]
14. Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. Vey M; Schäfer W; Berghöfer S; Klenk HD; Garten W J Cell Biol; 1994 Dec; 127(6 Pt 2):1829-42. PubMed ID: 7806563 [TBL] [Abstract][Full Text] [Related]
15. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen. Yang B; Hahn YS; Hahn CS; Braciale TJ J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912 [TBL] [Abstract][Full Text] [Related]
16. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells. Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044 [TBL] [Abstract][Full Text] [Related]
17. Trimming of antigenic peptides in an early secretory compartment. Snyder HL; Yewdell JW; Bennink JR J Exp Med; 1994 Dec; 180(6):2389-94. PubMed ID: 7964513 [TBL] [Abstract][Full Text] [Related]
18. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide. Knuehl C; Spee P; Ruppert T; Kuckelkorn U; Henklein P; Neefjes J; Kloetzel PM J Immunol; 2001 Aug; 167(3):1515-21. PubMed ID: 11466372 [TBL] [Abstract][Full Text] [Related]
19. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636 [TBL] [Abstract][Full Text] [Related]
20. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. López D; Del Val M J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]